The ARASEC study prospectively examined darolutamide plus ADT in US men with mHSPC, but used a historical control group receiving ADT monotherapy from the phase 3 CHAARTED trial for matching and ...

Financial concerns, inconsistent preventive care, and limited access to credible information are influencing health decisions across life stages.

Trehalase and NGAL could be strong and consistent independent predictors of ESKD, while β-catenin and IL-18 might be less stable or less predictive.

Associations with increased HDP risk seen for total cholesterol, LDL cholesterol, triglycerides, haptoglobin, ApoB.

The ongoing LEGEND phase 2 trial is testing a novel, investigational non-viral, intravesical gene therapy (EG-70) in patients with BCG-unresponsive NMIBC to elicit a local innate and adaptive immune ...